Impact of right-ventricular apical pacing on the optimal left-ventricular lead positions measured by phase analysis of SPECT myocardial perfusion imaging

Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1224-31. doi: 10.1007/s00259-014-2693-y. Epub 2014 Feb 28.

Abstract

Purpose: The use of SPECT phase analysis to optimize left-ventricular (LV) lead positions for cardiac resynchronization therapy (CRT) was performed at baseline, but CRT works as simultaneous right ventricular (RV) and LV pacing. The aim of this study was to assess the impact of RV apical (RVA) pacing on optimal LV lead positions measured by SPECT phase analysis.

Methods: This study prospectively enrolled 46 patients. Two SPECT myocardial perfusion scans were acquired under sinus rhythm with complete left bundle branch block and RVA pacing, respectively, following a single injection of (99m)Tc-sestamibi. LV dyssynchrony parameters and optimal LV lead positions were measured by the phase analysis technique and then compared between the two scans.

Results: The LV dyssynchrony parameters were significantly larger with RVA pacing than with sinus rhythm (p ~0.01). In 39 of the 46 patients, the optimal LV lead positions were the same between RVA pacing and sinus rhythm (kappa = 0.861). In 6 of the remaining 7 patients, the optimal LV lead positions were along the same radial direction, but RVA pacing shifted the optimal LV lead positions toward the base.

Conclusion: The optimal LV lead positions measured by SPECT phase analysis were consistent, no matter whether the SPECT images were acquired under sinus rhythm or RVA pacing. In some patients, RVA pacing shifted the optimal LV lead positions toward the base. This study supports the use of baseline SPECT myocardial perfusion imaging to optimize LV lead positions to increase CRT efficacy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Arrhythmia, Sinus / diagnostic imaging
  • Arrhythmia, Sinus / therapy*
  • Cardiac Resynchronization Therapy / methods*
  • Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Perfusion Imaging*
  • Radiopharmaceuticals / therapeutic use
  • Technetium Tc 99m Sestamibi / therapeutic use
  • Ventricular Function, Left
  • Ventricular Function, Right

Substances

  • Radiopharmaceuticals
  • Technetium Tc 99m Sestamibi